Managed Access Agreements: A New Model Pathway for The Reimbursement of Non-Oncology Drugs in England Approved Under European Adaptive Pathways?

VALUE IN HEALTH(2016)

引用 4|浏览2
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要